BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Citi
Cipla
Medtronic
US Department of Justice
UBS
Novartis
Cerilliant
AstraZeneca
Fish and Richardson

Generated: January 18, 2018

DrugPatentWatch Database Preview

Wilshire Pharms Inc Company Profile

« Back to Dashboard

What is the competitive landscape for WILSHIRE PHARMS INC, and what generic and branded alternatives to WILSHIRE PHARMS INC drugs are available?

WILSHIRE PHARMS INC has three approved drugs.



Summary for Wilshire Pharms Inc
US Patents:0
Tradenames:3
Ingredients:3
NDAs:3

Drugs and US Patents for Wilshire Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wilshire Pharms Inc PERPHENAZINE perphenazine TABLET;ORAL 205973-001 Dec 17, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wilshire Pharms Inc PERPHENAZINE perphenazine TABLET;ORAL 205973-002 Dec 17, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wilshire Pharms Inc CARISOPRODOL carisoprodol TABLET;ORAL 205126-001 Jul 8, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wilshire Pharms Inc TIAGABINE HYDROCHLORIDE tiagabine hydrochloride TABLET;ORAL 206857-002 Oct 13, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wilshire Pharms Inc TIAGABINE HYDROCHLORIDE tiagabine hydrochloride TABLET;ORAL 206857-003 Oct 13, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wilshire Pharms Inc TIAGABINE HYDROCHLORIDE tiagabine hydrochloride TABLET;ORAL 206857-001 Oct 13, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wilshire Pharms Inc CARISOPRODOL carisoprodol TABLET;ORAL 205126-002 Jul 8, 2015 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wilshire Pharms Inc PERPHENAZINE perphenazine TABLET;ORAL 205973-004 Dec 17, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wilshire Pharms Inc PERPHENAZINE perphenazine TABLET;ORAL 205973-003 Dec 17, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wilshire Pharms Inc TIAGABINE HYDROCHLORIDE tiagabine hydrochloride TABLET;ORAL 206857-004 Oct 13, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
AstraZeneca
Dow
McKinsey
Baxter
Daiichi Sankyo
Medtronic
US Army
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot